The approval of brensocatib for use in patients with bronchiectasis could offer the first treatment directly addressing the ...

May is a busy month for health awareness observations. Throughout the month, we’ve covered topics related to stroke, women’s ...

0 Asymptomatic Never diagnosed to have ABPA in the past, presentation with controlled asthma (according to GINA guidelines) and meeting the diagnostic criteria of ABPA (Box 6) 1 Acute Never ...

BACKGROUND Bronchiectasis is a chronic suppurative lung disease characterised by irreversible dilation of the bronchi and persistent purulent sputum. The immunopathology of the disease was studied ...

An estimated 5.17% of patients with inflammatory bowel diseases also have bronchiectasis, as shown in chest CT scans of patients with IBD.

A once-daily oral therapy targeting neutrophilic inflammation has shown promise in reducing exacerbations in patients with ...

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...

Infections and allergies can cause thick, glue-like nasal mucus. Environmental factors, like a dry climate, can also contribute to this. Nasal mucus is created by the tissue lining of your nose ...

Panelists discuss how the heterogeneity of bronchiectasis requires precise phenotyping and a treatable traits approach to ...

He advised her that if she had been coughing for two weeks then she should go and get her sputum tested. He's not muscular, can't see through walls and doesn't have a cape. Instead Bulgam Bhai is ...

We also look at when a person should seek medical help. Sinusitis is an infection of the sinuses that can cause a buildup of mucus and swelling. According to the American Academy of Allergy ...

Byondis has filed its HER2-targeting antibody-drug conjugate (ADC) trastuzumab duocarmazine in the US and Europe, setting up possible approvals next year and a showdown with heavyweight ...